This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The global aseptic pharma processing market was valued to be $10,633.3 million in 2020 and is expected to reach $24,364.0 million by 2031, witnessing a CAGR of 7.90% during the forecast period 2021-2031.
Market Report Coverage - Aseptic Pharma Processing Market
Market Segmentation
- Product - Corticosteroids, Long-Acting Beta Agonists/Long-Acting Muscarinic Antagonists, Antibiotics, and Others
- Technology - Drying, Lyophilization, Closed Vial Technology, Blow-Fill-Seal Technology, and Others
Regional Segmentation
- North America - U.S., Canada
- Europe - Germany, France, Italy, U.K., Spain, and Rest-of-Europe
- Asia-Pacific - China, Japan, Australia, India, South Korea, and Rest-of-Asia-Pacific (RoAPAC)
- Rest-of-the-World
Market Growth Drivers
- Reduced Risk of High-Cost Product Loss
- High Growth in the Generics and Biopharmaceuticals Markets
- Growing Demand for Contract Manufacturing Organizations (CMOs) for Aseptic Manufacturing of Pharmaceutical Products
Market Challenges
- High Capital Investment
- Lack of Skilled Personnel
Market Opportunities
- Emergence of Data within the Aseptic Processing Industry
- Growing Demand for Automated Products in Aseptic Pharma Processing at the Pharmaceutical Companies
- Increasing Investment in R&D
Key Companies Profiled
Abbvie Inc., Lonza Group, Baxter International Inc., August Bioservices, Vetter Pharma, Recipharm AB, Berkshire Sterile Manufacturing, Recro Pharma, Curia, Samsung Biologics, Symbiosis Pharmaceutical Services, Catalent Pharma Solutions Inc., Alcami Corporation, Wuxi AppTec
Key Questions Answered in this Report:
- What are the major drivers, challenges, and opportunities of the global aseptic pharma processing market?
- What are the key developmental strategies implemented by the key players to stand out in this market?
- Who are the leading companies dominating the global aseptic pharma processing market? What is the share of these companies in the global aseptic pharma processing market?
- What are the regulations pertaining to the global aseptic pharma processing market? What initiatives are implemented by different government bodies regulating the development and commercialization of aseptic pharma processing?
- How is each segment of the global aseptic pharma processing market expected to grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2031?
- How will the industry of aseptic pharma processing evolve during the forecast period 2021-2031?
- What is the market scenario for the aseptic pharma processing market in different regions?
- What are the key trends of different regions in the aseptic pharma processing market? Which country would contribute to the highest sales of the aseptic pharma processing market during the forecast period 2021-2031?
- What has been the impact of COVID-19 on the aseptic pharma processing market?
Market Overview
Aseptic processing has had been in commercial application since the 1950s. The requirement for aseptic manufacturing was raised when there was no suitable sterilization method for heat-sensitive pharmaceutical products that could not be autoclaved in the container. However, the drugs have to be sterile since then, the standards of aseptic manufacturing for the medicinal drugs were specified and standardized.
North America represented one of the most attractive markets amongst all the markets in the world for aseptic pharma processing in 2020. However, Europe is anticipated to gain more market shares than North America in the coming years, which can be attributed to a large number of contract drug manufacturers (CDMOs) present in the region. Also, the demand for aseptic processing is higher in European countries. However, China is expected to be the fastest-growing nation globally, with many local manufacturers in the region.
The global aseptic pharma processing market was valued to be $10,633.3 million in 2020 and is expected to reach $24,364.0 million by 2031, witnessing a CAGR of 7.90% during the forecast period 2021-2031.
The growth is attributed to the reduced risk of high-cost product loss, high growth in the generics and biopharmaceuticals markets, and growing demand for contract manufacturing organizations (CMOs) for aseptic manufacturing of pharmaceutical products. Further, continued significant investments by biotechnology firms to improve the aseptic processing technology by incorporating automated instruments has also promoted the prominence of the aseptic pharma processing market.
Within the research report, the market is segmented based on product, technology, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The exponential rise in the demand for biopharmaceuticals such as vaccines and other drugs have lead to an increase in the aseptic processing facilities to manufacture pharmaceuticals in a standardised mode. Further, the expansion in the number of CDMOs have also allowed the adoption of specific aseptic processing technologies. Companies such as Baxter International have been incorporating major strategies to enhance their market presence via key developments. The other major contributors to the market include companies such as Recipharm AB, Recro Pharma, and Lonza Group, among others.
Based on region, North America holds the largest share of the aseptic pharma processing market due to standardized regulatory scenarios and a large number of companies offering aseptic processing. Further, substantial investments made by biotechnology companies to improve the manufacturing facilities and advancing automation technologies along with the rise in per capita income in the region are also fuelling the growth of the respective market. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.
Table of Contents
1 Product Definition
1.1 Inclusions
1.2 Exclusions
2 Scope of the Work
2.1 Overview: Report Scope
2.2 Segmentation of the Global Aseptic Pharma Processing Market
2.3 Assumptions and Limitations
2.4 Key Questions Answered by this Report
3 Research Methodology
3.1 Global Aseptic Pharma Processing Market: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model
3.5 Criteria for Company Profiling
4 Markets
4.1 Market Overview
4.2 Global Aseptic Pharma Processing Market: Future Potential
4.2.1 Ecosystem Participants
4.3 Impact of COVID-19 on the Global Aseptic Pharma Processing Market
4.3.1 Patent Analysis
4.3.1.1 Introduction
4.3.1.2 Patent Landscape
5 Global Aseptic Pharma Processing Market: Industry Analysis
5.1 Overview
5.2 Policies and Regulatory Framework
5.2.1 Overview
5.2.2 Regulatory Framework in the U.S.
5.2.3 Regulatory Framework in EU4 (Germany, France, Italy, Spain) and the U.K.
5.2.4 Regulatory Framework in Asia-Pacific
5.3 Market Dynamics
5.3.1 Reduced Risk of High-Cost Product Loss
5.3.2 High Growth in the Generics and Biopharmaceuticals Markets
5.3.3 Growing Demand for Contract Manufacturing Organizations (CMOs) for Aseptic Manufacturing of Pharmaceutical Products
5.4 Market Challenges
5.4.1 High Capital Investment
5.4.2 Lack of Skilled Personnel
5.5 Market Opportunities
5.5.1 Emergence of Data within the Aseptic Processing Industry
5.5.2 Growing Demand for Automated Products in Aseptic Pharma Processing at the Pharmaceutical Companies
5.5.3 Increasing Investment in R&D
5.5.4 Competitive Landscape
5.6 New Offerings
5.7 Funding and Investments
5.8 Mergers and Acquisitions
5.9 Synergistic Activities
5.1 Market Share Analysis, By Company
6 Technology
6.1 Global Aseptic Pharma Processing Market (by Technology)
6.1.1 Drying
6.1.2 Lyophilization
6.1.3 Closed Vial Technology
6.1.4 Blow-Fill-Seal Technology
6.1.5 Others
7 Products
7.1 Global Aseptic Pharma Processing Market (by Product)
7.1.1 Corticosteroids
7.1.2 Long-Acting Beta Agonists/Long-Acting Muscarinic Antagonists
7.1.3 Antibiotics
7.1.4 Others
8 Region
8.1 North America
8.1.1 U.S.
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 U.K.
8.2.3 France
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest-of-Europe
8.3 Asia-Pacific
8.3.1 Market Dynamics
8.3.2 Japan
8.3.3 China
8.3.4 India
8.3.5 Australia
8.3.6 South Korea
8.3.7 Rest-of-Asia-Pacific
8.4 Rest-of-the-World
9 Markets - Competitive Benchmarking & Company Profiles
9.1 Company Profile
9.2 Abbvie Inc.
9.2.1 Company Overview
9.2.1.1 Role of Abbvie Inc. in Global Aseptic Pharma Processing Market
9.2.1.2 Abbvie Inc.: Product Portfolio
9.2.2 Financials
9.2.3 SWOT Analysis
9.3 Lonza Group
9.3.1 Company Overview
9.3.1.1 Role of Lonza Group in Global Aseptic Pharma Processing Market
9.3.1.2 Lonza Group : Product Portfolio
9.3.2 Financials
9.3.3 SWOT Analysis
9.4 Baxter International Inc.
9.4.1 Company Overview
9.4.1.1 Role of Baxter International Inc. in the Global Aseptic Pharma Processing Market
9.4.1.2 Baxter International Inc. : Product Portfolio
9.4.2 Financials
9.4.3 SWOT Analysis
9.5 August Bioservices
9.5.1 Company Overview
9.5.1.1 Role of August Bioservices in the Global Aseptic Pharma Processing Market
9.5.1.2 August Bioservices: Product Portfolio
9.5.2 SWOT Analysis
9.6 Vetter Pharma
9.6.1 Company Overview
9.6.1.1 Role of Vetter Pharma in Global Aseptic Pharma Processing Market
9.6.1.2 Vetter Pharma : Product Portfolio
9.6.2 SWOT Analysis
9.7 Recipharm AB
9.7.1 Company Overview
9.7.1.1 Role of Recipharm AB in Global Aseptic Pharma Processing Market
9.7.2 SWOT Analysis
9.8 Berkshire Sterile Manufacturing
9.8.1 Company Overview
9.8.1.1 Role of Berkshire Sterile Manufacturing in Global Aseptic Pharma Processing Market
9.8.2 SWOT Analysis
9.9 Recro Pharma
9.9.1 Company Overview
9.9.1.1 Role of Recro Pharma in Global Aseptic Pharma Processing Market
9.9.2 SWOT Analysis
9.1 Curia
9.10.1 Company Overview
9.10.1.1 Role of Curia in Global Aseptic Pharma Processing Market
9.10.2 SWOT Analysis
9.11 Samsung Biologics
9.11.1 Company Overview
9.11.1.1 Role of Samsung Biologics in the Global Aseptic Pharma Processing Market
9.11.1.2 Samsung Biologics : Overall Product Portfolio
9.11.2 Financials
9.11.3 SWOT Samsung Biologics Analysis
9.12 Symbiosis Pharmaceutical Services
9.12.1 Company Overview
9.12.1.1 Role of Symbiosis Pharmaceutical Services in the Global Aseptic Pharma Market
9.12.1.2 Symbiosis Pharmaceutical Services: Overall Product Portfolio
9.12.2 SWOT Analysis
9.13 Catalent Pharma Solutions Inc.
9.13.1 Company Overview
9.13.1.1 Role of Catalent Pharma Solutions Inc.in the Global Aseptic Pharma Market
9.13.1.2 Catalent Pharma Solutions Inc.: Overall Product Portfolio
9.13.2 Financials
9.13.3 SWOT Analysis
9.14 Alcami Corporation
9.14.1 Company Overview
9.14.1.1 Role of Alcami Corporation in the Global Aseptic Pharma Market
9.14.1.2 Alcami Corporation : Overall Product Portfolio
9.14.2 SWOT Analysis
9.15 Wuxi AppTec
9.15.1 Company Overview
9.15.2 Role of Wuxi AppTec in the Global Aseptic Pharma Processing Market
9.15.3 Financials
9.15.4 Key Insights About Financial Health of the Company
9.15.5 SWOT Analysis
List of Figures
Figure 1: Global COVID-19 Vaccination Scenario (2021)
Figure 2: Global Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 3: Global Aseptic Pharma Processing Market: Impact Analysis
Figure 4: Global Aseptic Pharma Processing Market (by Product Type), $Million, 2020, 2025 and 2031
Figure 5: Global Aseptic Pharma Processing Market (by Technology), $Million, 2020, 2025, and2031
Figure 6: Global Aseptic Pharma Processing Market (by Region), 2020 and 2031
Figure 7: Share of Key Market Strategies and Developments, January 2017- December 2021
Figure 8: Global Aseptic Pharma Processing Market (by Segment)
Figure 9: Global Aseptic Pharma Processing Market Methodology
Figure 10: Figure 3.2: Primary Research Methodology
Figure 11: Bottom-Up Approach (Segment-Wise Analysis)
Figure 12: Global Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 13: Ecosystem: CDMOs
Figure 14: Impact of COVID-19 on the Global Aseptic Pharma Processing Market, $Million, 2020-2026
Figure 15: Patent Analysis (by Year), 2018-2021
Figure 16: Global Aseptic Pharma Processing Market, Business Dynamics
Figure 17: Share of Key Market Strategies and Developments, January 2017- December 2021
Figure 18: Share of New Offerings (by Company), January 2017- December 2021
Figure 19: Share of Fundings and Investments (by Company), January 2017- December 2021
Figure 20: Share of Mergers and Acquisitions (by Company), January 2017- December 2021
Figure 21: Share of Synergistic Activities (by Company), January 2017- December 2021
Figure 22: Market Share Analysis for Global Aseptic Pharma Processing Market, 2020
Figure 23: Global Aseptic Pharma Processing Market (by Technology)
Figure 24: Global Aseptic Pharma Processing Market (Drying), $Million, 2020-2031
Figure 25: Global Aseptic Pharma Processing Market (Lyophilization), $Million, 2020-2031
Figure 26: : Global Aseptic Pharma Processing Market (Closed Vial Technology), $Million, 2020-2031
Figure 27: : Global Aseptic Pharma Processing Market (Blow-Fill-Seal Technology), $Million, 2020-2031
Figure 28: Global Aseptic Pharma Processing Market (Others), $Million, 2020-2031
Figure 29: Global Aseptic Pharma Processing Market (by Product)
Figure 30: : Global Aseptic Pharma Processing Market (Corticosteroids), $Million, 2020-2031
Figure 31: Global Aseptic Pharma Processing Market (Long-Acting Muscarinic Antagonists), $Million, 2020-2031
Figure 32: Global Aseptic Pharma Processing Market (Antibiotics), $Million, 2020-2031
Figure 33: Global Aseptic Pharma Processing Market (Others), $Million, 2020-2031
Figure 34: Global Aseptic Pharma Processing Market (by Region), 2020-2031
Figure 35: Share of North America Aseptic Pharma Processing Market Revenue (by Country), $Million, 2020 and 2031
Figure 36: North America: Market Dynamics
Figure 37: U.S. Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 38: Canada Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 39: Share of Europe Aseptic Pharma Processing Market (by Country), $Million, 2021-2031
Figure 40: Europe: Market Dynamics
Figure 41: Germany Aseptic Pharma Processing Market Revenue, $Million, 2020-2031
Figure 42: U.K. Pharma Processing Market Revenue, $Million, 2020-2031
Figure 43: France Pharma Processing Market Revenue, $Million, 2020-2031
Figure 44: Italy Pharma Processing Market Revenue, $Million, 2020-2031
Figure 45: Spain Pharma Processing Market Revenue, $Million, 2020-2031
Figure 46: Rest-of-Europe Pharma Processing Market Revenue, $Million, 2020-2031
Figure 47: Asia-Pacific Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 48: Asia-Pacific: Market Dynamics
Figure 49: Revenue Contributions of Various Countries in Asia-Pacific, $Million, 2020 and 2031
Figure 50: Japan Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 51: China Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 52: India Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 53: Australia Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 54: South Korea Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 55: Rest-of-APAC Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 56: Rest-of-the-World Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 57: Shares of Key Company Profiles
Figure 58: Abbvie, Inc.: Overall Financials, $Million, 2018-2020
Figure 59: Abbvie, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 60: Abbvie, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 61: Abbvie, Inc.: SWOT Analysis
Figure 62: Lonza Group: Overall Financials, $Million, 2018-2020
Figure 63: Lonza Group: R&D Expenditure, $Million, 2018-2020
Figure 64: Lonza Group: SWOT Analysis
Figure 65: Baxter International Inc.: Overall Financials, $Million, 2018-2020
Figure 66: Baxter International Inc. Revenue (by Segment), $Million, 2018-2020
Figure 67: Baxter International Inc. Revenue (by Region), $Million, 2018-2020
Figure 68: Baxter International Inc.: R&D Expenditure, $Million, 2018-2020
Figure 69: Baxter International Inc.: SWOT Analysis
Figure 70: August Bioservices: SWOT Analysis
Figure 71: Vetter Pharma: SWOT Analysis
Figure 72: Recipharm AB: Overall Product Portfolio
Figure 73: Recipharm AB: SWOT Analysis
Figure 74: Berkshire Sterile Manufacturing: Overall Product Portfolio
Figure 75: Berkshire Sterile Manufacturing: SWOT Analysis
Figure 76: Recro Pharma : Overall Product Portfolio
Figure 77: Recro Pharma: SWOT Analysis
Figure 78: Curia: Overall Product Portfolio
Figure 79: Curia: SWOT Analysis
Figure 80: Samsung Biologics: Overall Financials, $Million, 2018-2020
Figure 81: Samsung Biologics Revenue (by Region), $Million, 2018-2020
Figure 82: Samsung Biologics: SWOT Analysis
Figure 83: Symbiosis Pharmaceutical Services: SWOT Analysis
Figure 84: Catalent Pharma Solutions Inc: Overall Financials, 2019-2021
Figure 85: Catalent Pharma Solutions Inc: Company Revenue (by Segments), 2019-2021
Figure 86: Catalent Pharma Solutions Inc.: R&D Expenditure, 2019-2021
Figure 87: Catalent Pharma Solutions Inc.: SWOT Analysis
Figure 88: Alcami Corporation: SWOT Analysis
Figure 89: Wuxi AppTec: Overall Product Portfolio
Figure 90: Wuxi AppTec: Overall Financials, 2018-2020
Figure 91: Wuxi AppTec: Revenue (by Segment), 2018-2020
Figure 92: Wuxi AppTec: Revenue (by Region), 2018-2020
Figure 93: Wuxi AppTec: R&D Expenditure, 2018-2020
Figure 94: Wuxi AppTec: SWOT Analysis
Companies Mentioned
- Abbvie Inc.
- Lonza Group
- Baxter International Inc.
- August Bioservices
- Vetter Pharma
- Recipharm AB
- Berkshire Sterile Manufacturing
- Recro Pharma
- Curia
- Samsung Biologics
- Symbiosis Pharmaceutical Services
- Catalent Pharma Solutions Inc.
- Alcami Corporation
- Wuxi AppTec
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 124 |
| Published | December 2021 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 11393.5 Million |
| Forecasted Market Value ( USD | $ 24364 Million |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
